SEC Company Response from Xtant Medical Holdings, (XTNT) — Jun 1, 2018
Xtant Medical Holdings, Inc.
Date: June 1, 2018 · CIK: 0001453593 · Accession: 0001144204-18-032157
AI Filing Summary & Sentiment
File numbers found in text: 333-224940
Letter
June 1, 2018
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Ada D. Sarmento
Erin Jaskot
Re: Xtant Medical Holdings, Inc.
Amendment No. 2 to Registration Statement on Form S-1
Filed May 30, 2018
File No. 333-224940
Request for Acceleration
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned, on behalf of Xtant Medical Holdings, Inc. (Company), respectfully requests that the effective date for the above-referenced Registration Statement be accelerated so that it will be declared effective at 4:30 p.m., Eastern Daylight Savings time, on June 4, 2018, or as soon thereafter as is practicable. or at such later time as the Company or its counsel may request via telephone call to the Staff.
Please call Amy Culbert of Fox Rothschild LLP at (612) 607-7287 to provide notice of effectiveness or if you have any questions or concerns regarding this matter.
We understand that the Staff of the United States Securities and Exchange Commission will consider this request as confirmation by the Company that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.
Thank you for your assistance in this matter.
Very truly yours,
XTANT MEDICAL HOLDINGS, INC.
Show Raw Text
CORRESP 1 filename1.htm June 1, 2018 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Ada D. Sarmento Erin Jaskot Re: Xtant Medical Holdings, Inc. Amendment No. 2 to Registration Statement on Form S-1 Filed May 30, 2018 File No. 333-224940 Request for Acceleration Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned, on behalf of Xtant Medical Holdings, Inc. (Company), respectfully requests that the effective date for the above-referenced Registration Statement be accelerated so that it will be declared effective at 4:30 p.m., Eastern Daylight Savings time, on June 4, 2018, or as soon thereafter as is practicable. or at such later time as the Company or its counsel may request via telephone call to the Staff. Please call Amy Culbert of Fox Rothschild LLP at (612) 607-7287 to provide notice of effectiveness or if you have any questions or concerns regarding this matter. We understand that the Staff of the United States Securities and Exchange Commission will consider this request as confirmation by the Company that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement. Thank you for your assistance in this matter. Very truly yours, XTANT MEDICAL HOLDINGS, INC. Carl O’Connell Chief Executive Officer cc: Amy E. Culbert, Fox Rothschild LLP